Asset Details
Do you wish to reserve the book?
De-implementation of inappropriate inhaled corticosteroid use in patients with COPD in general practice, results of a mixed methods study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
De-implementation of inappropriate inhaled corticosteroid use in patients with COPD in general practice, results of a mixed methods study
Do you wish to request the book?
De-implementation of inappropriate inhaled corticosteroid use in patients with COPD in general practice, results of a mixed methods study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
De-implementation of inappropriate inhaled corticosteroid use in patients with COPD in general practice, results of a mixed methods study
2025
Overview
Many patients with COPD use inhaled corticosteroids (ICS) without proper indication. We developed a multifaceted tailor-made de-implementation strategy—including a toolbox, communication plan, and training—to reduce inappropriate ICS use in general practice. We evaluated its effectiveness (i.e. decline in percentage of patients with COPD that use ICS) and other outcomes during a 15-month study in Drenthe, the Netherlands. Less patients (−4.7%,95%CI: 2.6–6.7%) used ICS at the end of follow-up and the percentage of ICS-users declined by 8.2% (95%CI: 2.9–13.4%) across the 14 practices that fully participated in the project. ICS user percentages declined significantly moreover time in the fully participation group than in the control group (beta-regression, β = −0.041,SE = 0.011,
p
< 0.01). While these findings are promising, further research is needed to assess additional penetration and sustainability of the strategy in the region and to explore the applicability of comparable regional ICS de-implementation plans.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 692/699
/ 692/700
/ Adrenal Cortex Hormones - administration & dosage
/ Adrenal Cortex Hormones - therapeutic use
/ Aged
/ Asthma
/ Chronic obstructive pulmonary disease
/ Female
/ Humans
/ Inappropriate Prescribing - prevention & control
/ Inappropriate Prescribing - statistics & numerical data
/ Male
/ Medicine
/ Nurses
/ Pneumology/Respiratory System
/ Pulmonary Disease, Chronic Obstructive - drug therapy
/ Steroids
